Hardman & Co’s analysts have direct experience of uncovering accounting frauds. In this article, Steve Clapham outlines why we might see a surge in them over the next few years. He is engaged by institutions to teach their fund managers and analysts how to identify risks brought about by such frauds. Hardman & Co is pleased to offer this service to private investors.
01 Aug 2018
The Monthly
Time Finance plc (TIME:LON), 45.8 | Allergy Therapeutics plc (AGY:LON), 8.8 | Arbuthnot Banking Group PLC (ARBB:LON), 830 | Avacta Group PLC (AVCT:LON), 71.5 | Burford Capital Limited (BUR:LON), 322 | City of London Investment Group PLC (CLIG:LON), 428 | TheraCryf PLC (TCF:LON), 0.2 | Genedrive Plc (GDR:LON), 1.2 | Koovs (KOOV:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Primary Health Properties PLC (PHP:LON), 91.2 | R.E.A. Holdings plc (RE:LON), 112 | Scancell Holdings Plc (SCLP:LON), 23.0 | Surface Transforms PLC (SCE:LON), 0 | Titon Holdings Plc (TON:LON), 80.0 | Warpaint London PLC (W7L:LON), 210 | Oxford BioMedica plc (OXB:LON), 578 | ValiRx PLC (VAL:LON), 0.2 | Tissue Regenix Group plc (LSW:STU), 0
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
The Monthly
Time Finance plc (TIME:LON), 45.8 | Allergy Therapeutics plc (AGY:LON), 8.8 | Arbuthnot Banking Group PLC (ARBB:LON), 830 | Avacta Group PLC (AVCT:LON), 71.5 | Burford Capital Limited (BUR:LON), 322 | City of London Investment Group PLC (CLIG:LON), 428 | TheraCryf PLC (TCF:LON), 0.2 | Genedrive Plc (GDR:LON), 1.2 | Koovs (KOOV:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Primary Health Properties PLC (PHP:LON), 91.2 | R.E.A. Holdings plc (RE:LON), 112 | Scancell Holdings Plc (SCLP:LON), 23.0 | Surface Transforms PLC (SCE:LON), 0 | Titon Holdings Plc (TON:LON), 80.0 | Warpaint London PLC (W7L:LON), 210 | Oxford BioMedica plc (OXB:LON), 578 | ValiRx PLC (VAL:LON), 0.2 | Tissue Regenix Group plc (LSW:STU), 0
- Published:
01 Aug 2018 -
Author:
Steve Clapham -
Pages:
40 -
Hardman & Co’s analysts have direct experience of uncovering accounting frauds. In this article, Steve Clapham outlines why we might see a surge in them over the next few years. He is engaged by institutions to teach their fund managers and analysts how to identify risks brought about by such frauds. Hardman & Co is pleased to offer this service to private investors.